Bettinger R, Loerz M, Meyer-Breiting E
ENT Department, University of Frankfurt-am-Main, Federal Republic of Germany.
Eur Arch Otorhinolaryngol. 1991;248(4):236-41. doi: 10.1007/BF00173663.
Forty-six patients with advanced head and neck squamous cell carcinomas received two courses of chemotherapy with cisplatinum and bleomycin before undergoing cancer surgery. After surgery, histological serial sections of the resection specimens were examined. Biopsies from each resected specimen were shock-frozen for immunohistochemical examinations using the monoclonal antibodies Ki-67 and RPN-511, which are associated with cell proliferation. In no case did the morphologic analysis demonstrate complete tumor regression after chemotherapy. Thirty-seven patients showed partial tumor regressions histologically, as seen by tumor shrinkage of more than 50%. Nine of the specimens showed only minor regressions, with shrinkage less than 50%. The immunostaining of the frozen sections revealed in all cases the expressions of the Ki-67 nuclear antigen and the presence of specific transferrin (RPN-511) receptors in the proliferative compartments of the carcinomas.
46例晚期头颈部鳞状细胞癌患者在接受癌症手术前接受了两疗程顺铂和博来霉素化疗。术后,对切除标本进行了组织学连续切片检查。从每个切除标本中获取的活检组织进行速冻,以便使用与细胞增殖相关的单克隆抗体Ki-67和RPN-511进行免疫组化检查。形态学分析在任何情况下均未显示化疗后肿瘤完全消退。37例患者组织学上显示部分肿瘤消退,表现为肿瘤缩小超过50%。9个标本仅显示轻微消退,缩小小于50%。冰冻切片的免疫染色在所有病例中均显示出Ki-67核抗原的表达以及癌组织增殖区中特异性转铁蛋白(RPN-511)受体的存在。